Discontinued — last reported Q3 '25
Loews Equity Method Investments increased by 1.8% to $2.91B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.2%, from $2.57B to $2.91B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 9.7% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.90B | $2.00B | $1.93B | $1.92B | $1.94B | $1.98B | $1.95B | $2.01B | $2.02B | $2.07B | $2.17B | $2.27B | $2.37B | $2.46B | $2.52B | $2.57B | $2.75B | $2.80B | $2.86B | $2.91B |
| QoQ Change | — | +5.2% | -3.2% | -0.8% | +1.3% | +1.8% | -1.1% | +2.9% | +0.4% | +2.7% | +4.8% | +4.6% | +4.1% | +4.0% | +2.4% | +2.1% | +7.1% | +1.7% | +2.1% | +1.8% |
| YoY Change | — | — | — | — | +2.3% | -1.1% | +1.1% | +4.9% | +4.1% | +5.0% | +11.3% | +13.1% | +17.2% | +18.7% | +15.9% | +13.1% | +16.3% | +13.8% | +13.5% | +13.2% |